PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse

OBJECTIVE: The aim of this study was to evaluate if our molecular algorithm, based on tumor circulating transcripts, may predict relapse risk in cutaneous malignant melanoma (CMM). RESULTS: The multi-marker panel was able to differentiate patients with CMM from HC with high diagnostic sensitivity an...

Descripción completa

Detalles Bibliográficos
Autores principales: Autilio, Chiara, Paolillo, Carmela, Lavieri, Maria Michela, Pocino, Krizia, De Paolis, Elisa, Di Stasio, Enrico, Marchetti, Paolo, Gian Carlo, Cappellini Antonini, Capoluongo, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689624/
https://www.ncbi.nlm.nih.gov/pubmed/29156734
http://dx.doi.org/10.18632/oncotarget.20177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689624/
https://www.ncbi.nlm.nih.gov/pubmed/29156734
http://dx.doi.org/10.18632/oncotarget.20177

Ejemplares similares